Lv1
48 积分 2022-07-04 加入
Polatuzumab vedotin combined with R‐ICE(Pola-R‐ICE)as second‐line therapy in relapsed/refractory diffuse large B-cell lymphoma
1个月前
已关闭
Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma
1个月前
已完结
Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant
1个月前
已完结
Comparative Efficacy and Safety of Beam and Team Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients
1个月前
已完结
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
2个月前
已完结
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
2个月前
已完结
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network
2个月前
已完结
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
2个月前
已完结
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
4个月前
已完结
皖公网安备34019202002308
